Primary Sclerosing Cholangitis: This Invention Can Allow Donor Livers to Stay “Alive” Longer Before Transplant
sasint / Pixabay

Primary Sclerosing Cholangitis: This Invention Can Allow Donor Livers to Stay “Alive” Longer Before Transplant

According to a story from mirror.co.uk, a new invention called OrganOx has the potential to make liver transplants more effective and more widely available in the UK. A liver transplant…

Continue Reading Primary Sclerosing Cholangitis: This Invention Can Allow Donor Livers to Stay “Alive” Longer Before Transplant
Biogen Releases The Latest Research Results Featuring its Multiple Sclerosis Drugs
qimono / Pixabay

Biogen Releases The Latest Research Results Featuring its Multiple Sclerosis Drugs

According to a story from sectorpublishingintelligence.co.uk, studies utilizing data gathered in the real-world treatment setting are highlighting the characteristics of two different therapies for multiple sclerosis (MS) developed by the…

Continue Reading Biogen Releases The Latest Research Results Featuring its Multiple Sclerosis Drugs
FDA Approves a Program for Expanded Treatment Access in Niemann-Pick Disease Type C
rawpixel / Pixabay

FDA Approves a Program for Expanded Treatment Access in Niemann-Pick Disease Type C

According to a story from ir.stockpr.com, the biotechnology company CTD Holdings, Inc., recently announced that the US Food and Drug Administration (FDA) has issued an approval for an individual Investigational…

Continue Reading FDA Approves a Program for Expanded Treatment Access in Niemann-Pick Disease Type C